Early Approval For Flonase Generic Puts Glaxo In A Bind

Law360, New York (February 24, 2006, 12:00 AM EST) -- A surprisingly early approval by U.S. regulators of a generic version of allergy treatment Flonase prompted GlaxoSmithKline Plc to rush to the courthouse this week, securing a restraining order that in effect also stopped shipments of its own authorized generic version.

Par Pharmaceutical Cos. abruptly halted its shipments of a generic version of Flonase after Glaxo Plc won a temporary restraining order against a generic version of the $900-million drug in a district court on Thursday.

The U.S. District Court for the District of Maryland granted...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.